Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $465
أنثيم
Elevance Health ELV | 0.00 |
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:
ELV) with a Outperform and raises the price target from $435 to $465.
Mizuho Maintains Outperform on Elevance Health, Raises Price Target to $465
Elevance Health ELV | 0.00 |